These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 19026035)

  • 1. Glycopeptide bone penetration in patients with septic pseudoarthrosis of the tibia.
    Garazzino S; Aprato A; Baietto L; D'Avolio A; Maiello A; De Rosa FG; Aloj D; Siccardi M; Biasibetti A; Massè A; Di Perri G
    Clin Pharmacokinet; 2008; 47(12):793-805. PubMed ID: 19026035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftriaxone bone penetration in patients with septic non-union of the tibia.
    Garazzino S; Aprato A; Baietto L; D'Avolio A; Maiello A; De Rosa FG; Aloj D; Siccardi M; Biasibetti A; Massè A; Di Perri G
    Int J Infect Dis; 2011 Jun; 15(6):e415-21. PubMed ID: 21497532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New lipoglycopeptides: a comparative review of dalbavancin, oritavancin and telavancin.
    Zhanel GG; Calic D; Schweizer F; Zelenitsky S; Adam H; Lagacé-Wiens PR; Rubinstein E; Gin AS; Hoban DJ; Karlowsky JA
    Drugs; 2010 May; 70(7):859-86. PubMed ID: 20426497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of isolates with reduced glycopeptide susceptibility in orthopedic device-related infections due to methicillin-resistant Staphylococcus aureus.
    Vaudaux P; Ferry T; Uçkay I; François P; Schrenzel J; Harbarth S; Renzoni A
    Eur J Clin Microbiol Infect Dis; 2012 Dec; 31(12):3367-74. PubMed ID: 22833247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and bone concentrations of teicoplanin and vancomycin: study in an animal model.
    Drago L; De Vecchi E; Fassina MC; Gismondo MR
    Drugs Exp Clin Res; 1998; 24(4):185-90. PubMed ID: 10051964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone and subcutaneous adipose tissue pharmacokinetics of vancomycin in total knee replacement patients.
    Bue M; Tøttrup M; Hanberg P; Langhoff O; Birke-Sørensen H; Thillemann TM; Andersson TL; Søballe K
    Acta Orthop; 2018 Feb; 89(1):95-100. PubMed ID: 28914105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are Vancomycin Trough Concentrations of 15 to 20 mg/L Associated With Increased Attainment of an AUC/MIC ≥ 400 in Patients With Presumed MRSA Infection?
    Hale CM; Seabury RW; Steele JM; Darko W; Miller CD
    J Pharm Pract; 2017 Jun; 30(3):329-335. PubMed ID: 27074786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility of Staphylococci and Enterococci to vancomycin and teicoplanin.
    Guzek A; Korzeniewski K; Nitsch-Osuch A; Rybicki Z; Prokop E
    Adv Exp Med Biol; 2013; 788():125-32. PubMed ID: 23835969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures].
    Fajardo Olivares M; Hidalgo Orozco R; Rodríguez Garrido S; Gaona Álvarez C; Sánchez Silos RM; Hernández Rastrollo R; Martínez Tallo E; Cordero Carrasco JL
    Rev Esp Quimioter; 2012 Mar; 25(1):25-30. PubMed ID: 22488538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Teicoplanin in cardiac surgery: intraoperative pharmacokinetics and concentrations in cardiac and mediastinal tissues.
    Martin C; Bourget P; Alaya M; Sertin A; Atlani C; Ennabli K; Said R
    Antimicrob Agents Chemother; 1997 May; 41(5):1150-5. PubMed ID: 9145887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy of teicoplanin in the treatment of bloodstream infection caused by methicillin-resistant coagulase-negative staphylococci.
    Yamada K; Ueda T; Nakajima K; Ichiki K; Tsuchida T; Otani N; Takahashi Y; Ikeuchi H; Uchino M; Koshiba M; Takesue Y
    J Infect Chemother; 2020 May; 26(5):459-464. PubMed ID: 31870587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of pharmacokinetics and bactericidal activity of teicoplanin and vancomycin.
    Lagast H; Dodion P; Klastersky J
    J Antimicrob Chemother; 1986 Oct; 18(4):513-20. PubMed ID: 2945811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Vancomycin AUC/MIC and Trough Concentration With Early Clinical Response in Enterococcus or Coagulase-Negative Staphylococcus Infection: A Prospective Study.
    Pitayakittiwong C; Sermsappasuk P; Meesing A; Jaisue S
    J Clin Pharmacol; 2024 Aug; 64(8):1006-1014. PubMed ID: 38639115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of dalbavancin against methicillin-resistant Staphylococcus aureus in the rat granuloma pouch infection model.
    Jabés D; Candiani G; Romanó G; Brunati C; Riva S; Cavaleri M
    Antimicrob Agents Chemother; 2004 Apr; 48(4):1118-23. PubMed ID: 15047510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of teicoplanin and vancomycin in vitro activity on clinical isolates of Staphylococcus aureus.
    Tascini C; Flammini S; Leonildi A; Ciullo I; Tagliaferri E; Menichetti F
    J Chemother; 2012 Aug; 24(4):187-90. PubMed ID: 23040680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penetration of vancomycin into epithelial lining fluid in healthy volunteers.
    Lodise TP; Drusano GL; Butterfield JM; Scoville J; Gotfried M; Rodvold KA
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5507-11. PubMed ID: 21911567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of a Vancomycin Pharmacokinetic Model and Trough Serum Concentrations in Pediatric Patients.
    Ploessl C; White C; Manasco K
    Pediatr Infect Dis J; 2015 Oct; 34(10):e244-7. PubMed ID: 26121203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative antibacterial effects of daptomycin, vancomycin and teicoplanin studied in an in vitro pharmacokinetic model of infection.
    Bowker KE; Noel AR; MacGowan AP
    J Antimicrob Chemother; 2009 Nov; 64(5):1044-51. PubMed ID: 19759041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro selection of resistance to vancomycin and teicoplanin in Enterococcus faecium and Enterococcus faecalis compared with Staphylococcus epidermidis.
    Markopulos E; Graninger W; Georgopoulos A
    J Antimicrob Chemother; 1998 Jan; 41(1):43-7. PubMed ID: 9511036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activities of vancomycin and teicoplanin against penicillin-resistant pneumococci in vitro and in vivo and correlation to pharmacokinetic parameters in the mouse peritonitis model.
    Knudsen JD; Fuursted K; Espersen F; Frimodt-Møller N
    Antimicrob Agents Chemother; 1997 Sep; 41(9):1910-5. PubMed ID: 9303383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.